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:ةصلاخلا 
:ثحبلا ةيفلخ عفخُي تٍناعف ثارٔ ٌّٔزغ مٍنآثنا ءاذن تٌذٍهقخنا ثاجلاعنا ٌٕكح اي ًةداع .تعئاشنا تٌذهجنا ضاشيِا مكاشي ٍي ْٕ عئاشنا مٍنآثنا ءاد ت
.تهٌٕغ تْاقَ ةشخف ىنإ جاخححٔ 
:فذهلا  ًجًٕنا لٕطنا ٔر مٌٕطنا طباُنا / وٍٕيداُنا سزٍن تيلاسٔ تٍناعف ىٍٍقح4601 .عئاشنا مٍنآثنا ءاد جلاع ًف شخيَٕاَ 
:ةيدهنملا  ّعًٕجي اي عي اعٌشي ٍٍثلاثٔ تسًخ مٍجسح ىح ، تٍجلاعنا تٌشٌشسنا تبشجخنا ِزْ ًف461  ىنإ مصح ةذًن لاْؤي طٌشي مك ٌاك .ثافآ
ف ًف جلاع ثاسهج دلاث مصا2  .ةشٍخِا جلاعنا تسهج ذعب شٓشأ تثلاثٔ تسهج مك مبق مٍنآثنا عًٍج ىٍٍقح ىح .مٌٕغ طباَ / وٍٕيداَ سزٍن عي عٍباسأ
ا ٌٕكٌ ايذُع( ًئزجٔ ، شٍٍغح كاُْ ٌٕكٌ لا ايذُع تباجخسا لا ، )ثافُن واح ءافخخا كاُْ ٌٕكٌ ايذُع( تهياك آَأ ىهع تباجخسلاا فُصح ضافخَلا
ثنا ىجح ًفمٍنآ 50.)شبكأ ٔأ ٪ 
:حئاتنلا  ًف تهياك تباجخسا ذْٕش60 (64.19 ٪،)  ًف تٍئزج تباجخسا1 (9..4 ٪،)  ًف تباجخسا وذعٔ1 (1..0  لذعي ٌاكٔ .مٍنآثنا ٍي )٪
ٔ تٍَاثنأ ىنِٔا جلاعنا ثاسهج ذعب ًًكاشخنا صٍهخخنا  تثناثنا06 ٪، .6 ٪،  ٔ64.19 ًنإخنا ىهع ٪،  تٌآَ ًف،تعباخًنا  ساكخَلاا لذعي ٌاك
2.6. .ًعٍبطنا غاشُنا عًُح ىنٔ واع مكشب تفٍفخ تٍبَاجنا ساثَا جَاك .٪ 
:جاتنتسلاا   ًجًٕنا لٕطنا ٔر مٌٕطنا طباُنا / وٍٕيداُنا سزٍن ٌأ ٔذبٌ4601 .عئاشنا مٍنآثنا ءاد جلاعن ٍيآٔ لاعف شخيَٕاَ 
:تايصىتلا اًب تساسذنا ًصٕح : ًهٌ 
4ٍي شبكا دذع لاخدا . . ىظشًنا 
2.مٍنآثنا ءاذن يذٍهقح جلاع لاًعخسأ سزٍهنا ٍي عُٕنا ازْ ٍٍب تَساقي تساسد مًع. 
ABSTRACT:  
Background: Verruca vulgaris is a common dermatological problem. The conventional treatments for verruca 
vulgaris are usually invasive, low efficacy, and need a long recovery period.  
Aims of study: evaluate the effectiveness and the safety of long pulsed Nd:YAG laser in the treatment of 
verruca vulgaris.  
Methodology: In this therapeutic clinical trial, thirty five patients with a total of 105 lesions were enrolled. Each 
patient was eligible for up to three treatment sessions at 2 weeks interval with long pulsed Nd:YAG laser. All 
verrucae were evaluated before every session and three months after the last treatment session. The response 
classifies as complete (when there is complete disappearance of lesions), no response when there was no change, 
and partial (when the reduction in verruca size 50% or greater).  
Results: complete response was seen in 96 (91.43%), partial response in 4 (3.81%), and no response in 5 
(4.76%) verruca. The cumulative clearance rate after first, second, third treatment sessions was 60%, 80%, and 
91.43 % respectively. At end of follow up, relapse rate was 2.08%. Side effects were generally mild and did not 
prevent normal activity.  
Conclusion: long pulsed Nd:YAG laser (1064nm) appears to be effective and safe for treatment of verruca 
vulgaris. 
Recommendations:  
1. Increase the sample size.  
2. Make comparative study with other traditional treatment modality for verruca vulgaris. 
Keywords: wart, Nd:YAG, laser, Verruca, 1064 nm. 
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INTRODUCTION:  
Warts are a benign proliferation of skin and mucosa that result from infection with human 
papillomavirus (HPVs). These viruses do not produce acute signs or symptoms but induce 
slow growing lesion that can remain subclinical for a long time, a subset of HPVs has been 
associated with the development of epithelial malignancy 
(1)
.   
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Warts occur at any age but unusual in infancy and early childhood. The incidence 
increases in the school years to reach a peak between the age of 12 and 16 years then declines 
sharply to the age of 20 and more gradually thereafter 
(2,3)
. HPV members of genus family 
papovaviruses, which are double stranded DNA viruses replicate inside the nucleus. Because 
they contain no envelope, they are resistant to drying, freezing, and solvents 
(4)
.  
Transmission of warts occurs from direct person-to-person contact or indirectly by 
fomites 
(5)
. Cell mediated immunity appears to be the principle mechanism for the rejection of 
warts 
(6)
. Common warts occur largely between the age of 5and 20years and only 15% occur 
after the age of 35 
(7)
. They usually occur on the hands but are also often on the face and 
genitalia, or in other sites prone to trauma such as the knees or elbows, but they may occur 
anywhere on the skin surface, on the hands they favor the fingers and palm, periungual warts 
are common on nail biter 
(8)
.  
 Lesions range in size from pinpoint to more than 1 cm, most averaging about 5 mm. 
They grow in size for weeks to months and usually present as elevated, rounded papules with 
a rough, grayish surface, which is so characteristic that it has given us the word “verrucous,” 
used to describe lesions with similar surface character (e.g., seborrheic keratosis) 
(1)
. 
Modalities of treatment of common warts include topical, intralesional, systemic and surgical 
treatment 
(9, 10)
. No treatment modality is uniformly effective for all cases of viral warts or 
directly antiviral 
(7)
.  
Lasers can be an effective treatment option for both simple and recalcitrant warts 
(11)
. The 
most commonly used laser modalities for removal of wart consist of invasive lasers such as 
carbon dioxide and Er:YAG lasers, which ablate the warts layer by layer from the epidermis 
and the noninvasive lasers such as PDL and Nd:YAG lasers 
(1,12)
.  
Verruca vulgaris is caused by the human papillomavirus, which induces epidermal 
hyperplasia and neovascularization in affected skin. The use of non-ablative lasers is said to 
be based on the principle of targeting their vascular component which is evident histologically 
as dilated blood vessels in the dermal papillae 
(8, 13)
.  
The studies showed that CO2, PDL, Er:YAG and Nd:YAG are the most commonly 
studied laser modalities for wart treatment 
(14, 15)
.  
The Nd:YAG laser’s principal emission wavelength is at 1064 nm, still in the infrared 
range. The proposed mechanism of action for Nd:YAG laser has been coagulation and 
destruction of blood vessels in the papillary dermis of warts, so the target chromophore is 
hemoglobin 
(11)
. Also, hyperthermic treatment with this laser has been reported to cause 
remission with no recurrence in several case reports and case series 
(8, 11)
.  
 
AIMS OF STUDY 
Evaluate the effectiveness and the safety of long pulsed Nd:YAG laser in the treatment 
of verruca vulgaris. 
 
METHODOLOGY  
This study was carried out in the Laser Research Unit, College of Medicine / university 
of Kufa during the period from October 2016 to October 2017. The ethical approval was 
obtained from the Scientific Council of Dermatology and Venereology- Iraqi Board for 
Medical Specializations.  
This is a therapeutic clinical trial study for the evaluation of effectiveness and safety of 
long pulsed Nd:YAG laser in treatment of verruca vulgaris in Iraqi patients.  
Forty two patients (21 males and 21 females) with single or multiple verrucae were 
included in this study; Thirty five patients (17 males and 18 females) with a total of 105 
verrucae vulgaris lesions have completed the treatment.  The age of the enrolled patients 
ranged between 4-45 years.  
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Exclusion criteria were:  
1. Pregnant women.  
2. Active infections and chronic or uncontrolled systemic disease (diabetes, heart/kidney/liver 
disease).  
3. Children below 3 years. 
4. Wart with secondary bacterial infection.  
5. Immunocompromised patients (related to cancer, chemotherapy, systemic corticosteroid, 
transplant patients, etc.).  
6. Patient with seizure disorders. 
7. Patient who used other modalities of treatment in the last 1 month prior to the study.  
At the initial visits, all patients and the parents of pediatric patients were interviewed and 
a full history was taken regarding the: name, age, sex, occupation, marital status, duration of 
disease, site of the lesion, number of the lesions; single versus multiple; whether the laser 
treatment is the first time treatment of the lesion or second type of treatment, response of the 
lesions to previous treatment. Family history of warts, past medical history (states of immune 
suppression, organ transplantation or any chronic diseases), drugs history especially for 
corticosteroids and other immune suppressants or any previous treatment modality received 
for their warts.  
The careful physical examination was carried out to identify the site, size, and numbers of 
lesions. Color photographs for each patient were performed at the baseline before each 
treatment session and 3 months after the last session; photographs were taken using Sony-
digital, high sensitivity, 9 megapixels, DSCHX1 full HD 1080 camera in the same place with 
fixed illumination and distance.  
The procedure was fully described to the patients and the need for pre and post treatment 
photographs was explained to them. All patients signed a written informed consent about the 
nature of laser treatment, safety measures, possible side effects, and complications.  
The areas of involved tissues were cleaned with povidone iodine solution 10% and 
topical anesthesia was offered as an option and was infiltrated locally with 2% xylocaine 
hydrochloride without adrenaline with the patient recumbent. However, it is not required by 
most subjects.  
Subjects and clinicians wore protective goggles and masks during the treatments, and a 
smoke evacuator was used to remove any airborne viral particles. The study employed 1064-
nm long-pulsed Nd:YAG laser (Quanta system - DNA laser technology – ULTRALIGHT, 
Milan, Italy). The following parameters were used: spot size, 5 mm; pulse duration, 20 msec; 
and fluence, 200 J/cm2. Each patient was eligible for up to three treatments session 
administrated at two week intervals. In each session, the affected area was treated by the laser 
for a minimum of three passes depending on the thickness of lesion with a 1-mm margin on 
the surrounding skin. The endpoint looked for was just mild visible erythema of the treated 
area. After treatment, povidone iodine was dapped over the verruca and finally, a dressing 
was applied. Patients were told to keep the dressing for 1 day only and then leave the treated 
area opened. Post-treatment care also includes a local antibiotic in the form of fusidic acid (2 
% cream), twice daily. Analgesic in the form of paracetamol was prescribed if needed.  
   They were warned that it might be tender and might turn to black. At the next session, 
if there still verruca present,  the area will prepared as before and further laser treatment was 
performed exactly as above. However, if there was no obvious verruca present and normal 
skin striations continued across the area previously occupied by the verruca, then the verruca 
was deemed gone. During the treatment period, examination of the lesions was carried out to 
monitor the size of treated lesions and to report the degree of resolution.  
All verrucae were measured before each treatment session and at three months after the 
final treatment session to assess the response to treatment; the response was considered as:  
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1- Complete response when there is complete disappearance of the lesion  
2- Partial response which was defined as equal or > 50% or of verruca size. 
3- Poor response when the there is less than 50% of verruca size.  
4- No response when there was any change in verruca size. 
At the end of follow up period, patients were asked about the degree of pain and relapse 
of any treated lesion. Any complications or side effects of laser treatment were recorded.  
Statistical analysis was done by using SPSS(statistical package for social sciences) 
version 20 In which we use mean with standard deviation and number with percentage as 
descriptive statistics. For analysis, we used chi square test for categorical data. P value ≤0.05 
regarded significant.  
 
RESULTS:  
A total of 35 patients with common wart had been completed the study. Seven patients 
defaulted; because the treatment interfered with their work.    
(Table 1): Basic characteristics of subjects included in the study (n=35).   
 Mean±SD Range 
Age/years 22.85±12.76 4-45 
Duration/months 8.40±5.12 2-24 
There were 17 male (48.58%) and 18 female (51.43%). Their ages ranged from 5-45 
year with a mean ± SD of 22.85±12.76. The mean duration of the lesions was 8.40±5.12 
months. The number of the lesions treated was 105 wart lesions. The lesions were distributed 
mainly on the upper and lower extremities. The average number of treatment sessions 
required for clearance was varied from 1-3 sessions.  
 
Figure (1): the response rate of verrucous vulgaris after treatment with long pulse 
Nd:YAG laser 1064 nm.  
 
A complete response was seen in 96 (91.43%) verrucae. A partial response was seen in 4 
(3.81%) verrucae. Poor response was zero. No response was seen in 5 (4.76%) verruca  
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Figure (2): cumulative clearance rate at 1st, 2nd, and 3rd session following the 
treatment with long pulse Nd:YAG laser 1064 nm.  
 
 
The cumulative clearance rate after first, second and third treatment session was 60 %, 
80%, and 91.43 % respectively  
  
Figure (3): Clearance rates in the 1st, 2nd, and 3rd treatment session with long pulse 
Nd:YAG laser 1064 nm.  
 
The clearance rate after the first treatment session was seen in 63 (60%) lesions, and 
after the second session was seen in 21(20%) lesions, and after the third treatment session was 
seen in 12 (11.43%) lesions.  
 
Table (2): Association between the responses of verrucous vulgaris to long pulse 
Nd:YAG laser 1064 nm and previous history of other treatment options. 
 
 
      Treatment before 
Total P value 
No Yes 
Response 
Complete response 
35 61 96 
0.259 
87.5% 93.8% 91.4% 
Partial or no response 
5 4 9 
12.5% 6.2% 8.6% 
Total 
40 65 105 
 
100% 61.9% 100.0% 
In regarding of the association between the responses of verrucous vulgaris to long pulse 
Nd:YAG laser 1064 nm and previous history of other treatment options (local acid application 
and electrocautery), the differences appear to be not statistically significant (p value=0.259)  
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Table (3): comparison in duration of lesions between responded & not responded lesion 
  
Duration/ month 
Complete response no. (96) No or partial (9) response P value 
Mean   SD Mean    SD 
0.727 
8.36    5.39 8.60    3.57 
Regarding the duration of disease, the mean of duration ±SD of the lesions with full 
response (8.36 months± 5.39) and the mean of duration ±SD of the lesions with no response 
(8.60months ± 3.57), the P-value was 0.927 which is statistically insignificant. This implies 
that the duration of the disease has no role on the response of the lesions to treatment with 
long pulsed ND: YAG laser.  
 
Table (4): Associations between size of lesion and response to long pulse Nd:YAG 
laser 1064 nm.   
The associations between the size of the wart and the response to long pulse Nd:YAG 
laser 1064 nm, whether complete or partial or no response, was statistically non-significant 
(P-value0.909)  
 
Figure (4): Twenty five years old female with warts on the thumb (A) before treatment 
and (B) 3 months following treatment with long pulse Nd:YAG laser. 
 
 
Response 
               Size of lesion mm 
Total P value 
<=5mm  >5mm 
Complete Response 
48 48 96 
0.909 
50.0% 50.0% 100.0% 
Partial response 
2 2 4 
50.0% 50.0% 100.0% 
No response 
2 3 5 
40.0% 60.0% 100.0% 
Total 
52 53 105 
49.5% 50.5% 100.0% 
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The associations between the size of the wart and the response to long pulse Nd:YAG 
laser 1064 nm, whether complete or partial or no response, was statistically non-significant 
(P-value0.909)  
 
Table (5): Association between site of lesions and response rate to long pulse Nd:YAG 
laser 1064 nm.  
Site Complete response Partial response No response 
Fingers & hand 38 (95%) 1 (2.5%) 1 (2.5%) 
Palm 20 (90%) 0 2 (10%) 
Periungual 16 (80%) 2 (10%) 2 (10%) 
Dorsal surface of feet 13 (92%) 1 (7.14) 0 
Other site: forearm, arm  
thigh, leg 
10 (100%) 0 0 
Regarding the site of lesions, periungual warts showing the lowest cure rate of 80 
%.While those on arm; forearm; leg; thighs showing the best cure rate of 100 %.The cure rate 
on the hand and dorsal surface of the foot were comparable.   
At the end of the 3 months of follow up, only 2 (2.08%) lesions which were completely 
cleared lesions showed recurrence.  
The side effects were generally mild and did not prevent normal activity, which include 
transient pain during treatment was experienced in 10 (28.6%) patients; numbness post 
treatment was experienced in 3 (8.6%) patients; hemorrhagic bulla in the treated areas was 
apparent in 21(20%) lesions; hyperpigmentation was noted in 9 (8.6%) lesions which was 
transient and disappears at the end of follow up; hypopigmentation in 6 (5.7%) lesions, no 
scar and no nail dystrophy.  
 
DISCUSSION:  
Viral warts are a common dermatological disease. They are lesions of the skin and 
mucosa caused by HPV, can appear anywhere on the body with a usual incubation period of 
1–6 months (1).  
   In this present study, 35 Iraqi patients (17males and18 females) with a total of 105 
verrucae vulgaris were treated with long pulsed Nd:YAG laser (1064nm, 5mm spot size, 
200J/ cm2 fluence, and 20ms pulsed duration) for their common wart to evaluate its 
effectiveness and safety.  
   The result from this study shows that long pulsed Nd:YAG laser lead to a complete 
response in 96 verruca (91.4%).  
   The largest series of warts treated with Nd:YAG laser was reported by Han et al 
(16)
. 
The following parameters were used: spot size, 5mm; pulsed duration, 20msec; and fluence, 
200J/cm2 . Their overall success rate in 369 patients was 96%. They also reported that after 
the first, second, third, and fourth treatment sessions the clearance rate was 65%, 83%, 92%, 
and 96%, respectively. The clearance rate after the first treatment was also higher in the 
verruca vulgaris group (72.6%) than 64.7% in the periungual warts group and 44.1% in the 
deep palmoplantar warts group.  
In periungual and deep palmoplantar warts, the reported success rate was lower than 
that for other body areas. They also reported that after the first, second, third, and fourth 
treatment sessions the clearance rate for verruca vulgaris was72.6 %, 90%, 96.6%, and 99.6%, 
respectively. Side effect included transient numbness (15%), hemorrhagic bulla (7%), 
hyperpigmentation (5%), and hypopigmentation (4%), 2% of patients with periungual warts 
experienced nail dystrophy.   
The present study is in accordance with Han et al study, the present study shows that 
overall response rate was 91.4 %, and also show that after the first, second and third treatment 
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sessions the clearance rate was 60%,80%,and91.4%, respectively. Side effect included 
transient numbness (8.6%), hemorrhagic bullae (21%), hyperpigmentation (8.6%), and 
hypopigmentation (5.7%), no nail dystrophy, so in this present study, these results show less 
percentage of clearance rate and different side effect this may be due to small sample size, 
fewer sessions.  
    Kimura et al.
 (17) 
recently reported a series of 20 patients with a total of 34 lesions. All 
the subjects suffered from refractory hand and foot warts despite conventional treatments for 
more than 6 months. The patients were administrated up to six sessions of treatment, at 
intervals of 4 weeks between sessions, with long pulsed Nd:YAG at a spot size of 5 mm, 
pulse duration of 15msec and fluence of 150–185 J/cm2.  
    Evaluation of the treatment results at 24 weeks after the initial treatment showed 
complete clearance was observed for 56% (19/34) of the lesions, with 80% (27/34) of the 
lesions showing at least moderate improvement (≥51% improvement). During the study, no 
scarring, no pigmentary changes or serious adverse events were reported.  
The present study showed higher complete clearance rate of 91.43 %( 96/105) of the 
lesions and slightly more adverse effect. This may be attributed to the difference in 
parameters used, as Kimura at al used shorter pulse duration and lower fluence, and because 
the enrolled lesions only old and refractory that had failed to respond to conventional 
treatments while in the present study used lesions without previous treatment therapy and also 
lesions in which other modalities of treatment was used before.   
David Goldberg et al 
(18)
, 25 adult subjects with a total of 63 hand verrucae in a clinical 
trial were treated with a low energy (200mjoule) 1064nm Nd:YAG laser. Each subject was 
eligible for 3 treatments administered at monthly intervals. All verrucae were measured at 6 
months after the final treatment. Results showed complete response was seen in 19 (76%) 
patients and in 41 (65%) verrucae and showed no complication.  
Ugur Anil Bingol et al.
 (19)
 study included 51 patients who were treated for 146 
recalcitrant hand warts using 1064 nm long-pulsed Nd:YAG laser as follows: spot size, 3 mm; 
pulse duration, 23 ms; fluence, 180–200 J/cm2, the laser treatment method is novel because 
each treated wart was aligned at the intersection point of the circles of 3 laser pulses per 
session. Results of this study, 88.35% were successfully treated with one session and 100% of 
those that required a second treatment session were treated successfully, based on the 12 
month follow-up examination. Complications of this study were thin scars which observed 
in(11.64%), Hyperpigmentation was observed in (5.48%), hypopigmentation did not occur in 
any of the patients, and none of the patients had a recurrence at the 12-month post-treatment 
follow-up.in this present study, the present study achieved slightly  less complete  rate 
(91.4%)but in the present study showed no scar in any patient, this may be due to different 
parameter used ,also because overlapped triple circle pulse technique employed might have 
positively affected the success rate, the technique described here is facilitated delivery of 
maximum therapeutic laser energy to the core of the warts while delivering less, but sufficient 
energy to the periphery of the warts.  
Other modalities of treatments other than laser had been used for treatment of wart in 
Iraqi patients with variable success rate, oral zinc sulphate(89%) cure rate 
(20)
, BCG vaccine 
showed (39.7%)cure rate 
(21)
, intralesional zinc sulphate showed high cure rate(98%) two 
weeks after the third injection
(22)
, but it is difficult to compare the efficacy of these studies 
from this present study as these studies differ  in duration of treatment, number of sessions, 
parameters of patients  and type of warts.  
So this present study demonstrated that long pulsed ND:YAG laser (1064nm) is an 
effective and safe method to treat verruca vulgaris in Iraqi patients, as this is the first study 
done in Iraq using this type of laser in treatment of common warts, it is much easier than the 
daily application of keratolytic ,or caustic material with less side effect than  like CO2 laser, 
cryotherapy or electrocautery with higher success rate.   
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CONCLUSION 
 Long pulsed Nd:YAG laser (1064nm) appears to be effective and safe for treatment of 
verruca vulgaris. 
 
RECOMMENDATIONS:  
1. Increase the sample size.  
2. Make comparative study with other traditional treatment modality for verruca 
vulgaris. 
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